Work

Advanced renal cell cancer combination immunotherapy clinical trial (ARCITECT; HCRN GU 22-587).

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.4_suppl.tps492

Authors: Michael Thomas Serzan, Opeyemi Jegede, Mehmet Asim Bilen, David A. Braun, David Johnson Einstein, Naomi B. Haas, Hans J. Hammers, Jennifer King, Karie Runcie, Jeffrey A. Sosman, Cora N. Sternberg, Yuanquan (Aaron) Yang, Toni K. Choueiri, Sabina Signoretti, Michael B. Atkins

Institutions: Dana-Farber Cancer Institute, Winship Cancer Institute, Yale University, Beth Israel Deaconess Medical Center, Abramson Cancer Center, The University of Texas Southwestern Medical Center, Indiana University Health, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Columbia University Irving Medical Center, Northwestern University, Northwestern Medicine, Weill Cornell Medicine, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Pelotonia, The Ohio State University, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4391303033

Cites:

Cited by: 2

Related to: 10